Skip to main content

Table 2 Patient Demographics and Symptom Assessment

From: Early gene expression changes with rush immunotherapy

   

Skin Test Positivity*

Avg. Nasal

SymptomScore**

Patient

Age

Race

Bermuda

Ragweed

D. Pteryon

D.Farinae

Baseline

4 mos. Post-RIT

1

56

Caucasian

+

+

  

4.0

1.7

2

32

Caucasian

+

+

+

+

5.1

2.9

3

28

Indian

+

+

+

+

4.0

3.7

  1. * + = greater than or equal to 5 mm on skin prick testing
  2. ** Rhinitis Symptom Severity Score, Range 1 (no symptoms) to 7 (unbearably severe symptoms)
Back to article page

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us